Amgen crushed second-quarter forecasts late Tuesday. The news could push Amgen stock, already above its 50-day line, into a ...

Thousand Oaks, California-headquartered Amgen Inc. (AMGN) discovers, develops, and manufactures innovative medicines aimed at ...

For the second quarter, total revenues increased 9% to $9.2 billion in comparison to the second quarter of 2024. Product sales grew 9%, driven by 13% volume g ...

Amgen (AMGN) recently declared a $2.38 dividend per share, continuing its practice of rewarding shareholders, which aligns ...

Analysts estimate that Amgen will report an earnings per share (EPS) of $5.26. The announcement from Amgen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a closer look by investors of all stripes. Amgen delivered stellar first ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.